The Global Pharmaceutical Glass Packaging Market was valued at USD 23.9 billion in 2025 and is estimated to grow at a CAGR of 10.3% to reach USD 63.1 billion by 2035.
The pharmaceutical glass packaging market is being driven by the rising need for high-quality packaging that ensures product integrity and stability. Increasing demand for pharmaceutical products, supported by demographic shifts and a growing burden of long-term health conditions, is accelerating industry expansion. Glass remains a preferred material due to its superior chemical resistance and ability to maintain drug efficacy over time. Manufacturers are focusing on developing advanced packaging solutions that combine durability with improved performance. Continuous innovation in lightweight, break-resistant, and environmentally sustainable glass materials is enhancing safety standards while meeting regulatory expectations. These developments are strengthening the role of glass packaging as a critical component in pharmaceutical supply chains.
The pharmaceutical glass packaging market is also influenced by strict regulatory requirements focused on ensuring drug safety and preventing contamination. Global health authorities are enforcing comprehensive standards that require packaging materials to maintain product stability under various conditions. This has encouraged a shift toward higher-grade materials, particularly those offering enhanced chemical resistance and thermal stability. As a result, manufacturers are increasingly adopting advanced glass compositions to meet compliance standards and improve overall packaging reliability.
In 2025, the Type I borosilicate glass segment held a 62.6% share. This segment is gaining strong traction due to its superior resistance to chemical interactions and its ability to maintain stability under varying temperature conditions. The growing demand for sensitive pharmaceutical formulations is further supporting the adoption of this material. Regulatory requirements emphasizing the use of high-performance packaging materials are also contributing to the increased utilization of Type I borosilicate glass across the industry.
The tubular glass segment reached USD 11.2 billion in 2025. This segment is widely recognized for its precision, durability, and compatibility with advanced pharmaceutical applications. Its consistent structural properties and high resistance to chemical reactions make it suitable for critical packaging needs. Additionally, its compatibility with automated production systems has increased its adoption, allowing manufacturers to achieve greater efficiency and maintain product quality across large-scale operations.
North America Pharmaceutical Glass Packaging Market accounted for 35.3% share in 2025. The region is characterized by a strong focus on quality standards, regulatory compliance, and sustainable manufacturing practices. Increasing demand for advanced pharmaceutical packaging solutions is encouraging the adoption of high-purity glass materials and innovative coating technologies. The growing emphasis on product safety and contamination prevention is further supporting the use of high-performance glass packaging solutions. Additionally, government initiatives promoting sustainable materials are reinforcing the shift toward advanced glass packaging across the region.
Key companies operating in the Global Pharmaceutical Glass Packaging Market include Ardagh Group S.A., Beatson Clark Ltd., Bormioli Pharma S.p.A., Corning Incorporated, DWK Life Sciences GmbH, Gerresheimer AG, Hindustan National Glass & Industries Ltd., Nipro Corporation, Owens Illinois, Inc., Piramal Glass Limited, Schott AG, SGD Pharma (SGD S.A.), Shandong Pharmaceutical Glass Co., Ltd., Stevanato Group S.p.A., and Stölzle Glass Group. Companies in the Global Pharmaceutical Glass Packaging Market are strengthening their market position through continuous innovation, strategic collaborations, and capacity expansion. They are investing in research and development to create advanced glass formulations with improved chemical resistance and durability. Partnerships with pharmaceutical manufacturers are enabling better alignment with evolving packaging requirements. Companies are also expanding production capabilities to meet rising global demand and ensure a consistent supply. Sustainability initiatives, including the development of lightweight and recyclable glass solutions, are becoming a key focus area.
This product will be delivered within 2-4 business days.
The pharmaceutical glass packaging market is being driven by the rising need for high-quality packaging that ensures product integrity and stability. Increasing demand for pharmaceutical products, supported by demographic shifts and a growing burden of long-term health conditions, is accelerating industry expansion. Glass remains a preferred material due to its superior chemical resistance and ability to maintain drug efficacy over time. Manufacturers are focusing on developing advanced packaging solutions that combine durability with improved performance. Continuous innovation in lightweight, break-resistant, and environmentally sustainable glass materials is enhancing safety standards while meeting regulatory expectations. These developments are strengthening the role of glass packaging as a critical component in pharmaceutical supply chains.
The pharmaceutical glass packaging market is also influenced by strict regulatory requirements focused on ensuring drug safety and preventing contamination. Global health authorities are enforcing comprehensive standards that require packaging materials to maintain product stability under various conditions. This has encouraged a shift toward higher-grade materials, particularly those offering enhanced chemical resistance and thermal stability. As a result, manufacturers are increasingly adopting advanced glass compositions to meet compliance standards and improve overall packaging reliability.
In 2025, the Type I borosilicate glass segment held a 62.6% share. This segment is gaining strong traction due to its superior resistance to chemical interactions and its ability to maintain stability under varying temperature conditions. The growing demand for sensitive pharmaceutical formulations is further supporting the adoption of this material. Regulatory requirements emphasizing the use of high-performance packaging materials are also contributing to the increased utilization of Type I borosilicate glass across the industry.
The tubular glass segment reached USD 11.2 billion in 2025. This segment is widely recognized for its precision, durability, and compatibility with advanced pharmaceutical applications. Its consistent structural properties and high resistance to chemical reactions make it suitable for critical packaging needs. Additionally, its compatibility with automated production systems has increased its adoption, allowing manufacturers to achieve greater efficiency and maintain product quality across large-scale operations.
North America Pharmaceutical Glass Packaging Market accounted for 35.3% share in 2025. The region is characterized by a strong focus on quality standards, regulatory compliance, and sustainable manufacturing practices. Increasing demand for advanced pharmaceutical packaging solutions is encouraging the adoption of high-purity glass materials and innovative coating technologies. The growing emphasis on product safety and contamination prevention is further supporting the use of high-performance glass packaging solutions. Additionally, government initiatives promoting sustainable materials are reinforcing the shift toward advanced glass packaging across the region.
Key companies operating in the Global Pharmaceutical Glass Packaging Market include Ardagh Group S.A., Beatson Clark Ltd., Bormioli Pharma S.p.A., Corning Incorporated, DWK Life Sciences GmbH, Gerresheimer AG, Hindustan National Glass & Industries Ltd., Nipro Corporation, Owens Illinois, Inc., Piramal Glass Limited, Schott AG, SGD Pharma (SGD S.A.), Shandong Pharmaceutical Glass Co., Ltd., Stevanato Group S.p.A., and Stölzle Glass Group. Companies in the Global Pharmaceutical Glass Packaging Market are strengthening their market position through continuous innovation, strategic collaborations, and capacity expansion. They are investing in research and development to create advanced glass formulations with improved chemical resistance and durability. Partnerships with pharmaceutical manufacturers are enabling better alignment with evolving packaging requirements. Companies are also expanding production capabilities to meet rising global demand and ensure a consistent supply. Sustainability initiatives, including the development of lightweight and recyclable glass solutions, are becoming a key focus area.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Material Type, 2022-2035 (USD Billion & Million Units)
Chapter 6 Market Estimates and Forecast, by Manufacturing Process, 2022-2035 (USD Billion & Million Units)
Chapter 7 Market Estimates and Forecast, by Product Type, 2022-2035 (USD Billion & Million Units)
Chapter 8 Market Estimates and Forecast, by Drug Delivery Route, 2022-2035 (USD Billion & Million Units)
Chapter 9 Market Estimates and Forecast, by End Use, 2022-2035 (USD Billion & Million Units)
Chapter 10 Market Estimates and Forecast, by Region, 2022-2035 (USD Billion & Million Units)
Chapter 11 Company Profiles
Companies Mentioned
The companies profiled in this Pharmaceutical Glass Packaging market report include:- Ardagh Group S.A.
- Bormioli Pharma S.p.A.
- Corning Incorporated
- Gerresheimer AG
- Nipro Corporation
- Owens-Illinois, Inc.
- SCHOTT AG
- SGD Pharma (SGD S.A.)
- Stevanato Group S.p.A.
- Stölzle Glass Group
- Beatson Clark Ltd.
- DWK Life Sciences / DWK Life Sciences GmbH
- Shandong Pharmaceutical Glass Co., Ltd.
- Hindustan National Glass & Industries Ltd.
- Piramal Glass Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | March 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 23.9 Billion |
| Forecasted Market Value ( USD | $ 63.1 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
